Daiichi Sankyo Company, Limited (OTCPK:DSKYF) Q4 2023 Earnings Call Transcript April 25, 2024 2:00 AM ET Company Participants Kentaro Asakura - VP of Corporate Communications Department Hiroyuki ...

Bernstein analyst Miki Sogi assigned a Buy rating to Daiichi Sankyo Company (DSKYF – Research Report) today and set a price target of Yen6,400.00. The company’s shares closed last Friday at ...

DAIICHI SANKYO is expected to report sales of ¥407.31 billion, an increase of 19.63% over the same period last year.

Narrow-moat Daiichi Sankyo’s fourth-quarter revenue grew 30% year on year, which is in line with our optimistic expectations. Guidance for fiscal 2024 is above our expectations because of the ...

AstraZeneca secured partial rights to the Daiichi Sankyo compound in 2019 in a deal worth up to $6.9 billion. In 2023, the drug generated sales of $1.28 billion as a treatment for breast cancer ...